Dani Cushion - Innovid Corp Chief Officer
CTVDelisted Stock | USD 3.14 0.00 0.00% |
Executive
Dani Cushion is Chief Officer of Innovid Corp
Age | 47 |
Phone | 212 966 7555 |
Web | https://www.innovid.com |
Innovid Corp Management Efficiency
The company has Return on Asset of (0.0257) % which means that on every $100 spent on assets, it lost $0.0257. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0702) %, meaning that it generated no profit with money invested by stockholders. Innovid Corp's management efficiency ratios could be used to measure how well Innovid Corp manages its routine affairs as well as how well it operates its assets and liabilities.Innovid Corp has 21.83 M in debt with debt to equity (D/E) ratio of 0.09, which may show that the company is not taking advantage of profits from borrowing. Innovid Corp has a current ratio of 2.64, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Innovid to invest in growth at high rates of return.
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Michael Bondi | Comtech Telecommunications Corp | 51 | |
Marcy Graham | ADC Therapeutics SA | 58 | |
Brian Duggan | Comtech Telecommunications Corp | 82 | |
Nancy CPA | Comtech Telecommunications Corp | 64 | |
Eugenia Litz | ADC Therapeutics SA | N/A | |
Michael CPA | Comtech Telecommunications Corp | 52 | |
Brian JD | Belden Inc | 50 | |
Jon Opalski | Comtech Telecommunications Corp | 62 | |
Mohamed MD | ADC Therapeutics SA | 60 | |
Rich Luhrs | Comtech Telecommunications Corp | N/A | |
Jose MBA | ADC Therapeutics SA | 53 | |
Donald JD | Comtech Telecommunications Corp | 57 | |
Jay Wirts | Belden Inc | 54 | |
Jennie Kerr | Comtech Telecommunications Corp | N/A | |
Lisa Kallebo | ADC Therapeutics SA | N/A | |
Ashley Clark | Comtech Telecommunications Corp | N/A | |
Joia Thompson | ADTRAN Inc | N/A | |
Aaron CFA | Belden Inc | N/A | |
Keith Atwell | ADTRAN Inc | N/A | |
David Ege | ADC Therapeutics SA | 51 | |
Hiran Bhadra | Belden Inc | N/A |
Management Performance
Return On Equity | -0.0702 | |||
Return On Asset | -0.0257 |
Innovid Corp Leadership Team
Elected by the shareholders, the Innovid Corp's board of directors comprises two types of representatives: Innovid Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innovid. The board's role is to monitor Innovid Corp's management team and ensure that shareholders' interests are well served. Innovid Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innovid Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tanya AndreevKaspin, Executive Officer | ||
Tim Braz, VP Sales | ||
Stephanie Geno, Chief Officer | ||
Stephen Cook, General Counsel | ||
Ken Markus, Chief Officer | ||
John Williams, Head Relations | ||
Pr Netter, CEO CoFounder | ||
Michal Livny, Executive Resources | ||
Alex Rowe, Senior Sales | ||
Anthony Callini, Chief Officer | ||
Dani Cushion, Chief Officer | ||
David Helmreich, Chief Officer | ||
Jeff Austin, Senior Operations | ||
Kenneth Markus, Chief Officer | ||
Liel Golan, Executive Operations | ||
Yuval Pemper, Chief Officer | ||
Sarah Ripmaster, Senior Accounts | ||
Tal Chalozin, CoFounder CTO | ||
Arik Shahar, VP Measurement | ||
Guy Kuperman, Chief Officer |
Innovid Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innovid Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0702 | |||
Return On Asset | -0.0257 | |||
Profit Margin | (0.09) % | |||
Operating Margin | (0.04) % | |||
Current Valuation | 450.54 M | |||
Shares Outstanding | 150.92 M | |||
Shares Owned By Insiders | 7.27 % | |||
Shares Owned By Institutions | 55.65 % | |||
Number Of Shares Shorted | 3.46 M | |||
Price To Earning | 23.87 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Innovid Stock
If you are still planning to invest in Innovid Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Innovid Corp's history and understand the potential risks before investing.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |